These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3931104)

  • 1. The pH dependent platelet utilization of arachidonic acid and a thromboxane A2 mimetic, in vitro.
    Kerry PJ; Paton CJ
    Pharmacol Res Commun; 1985 Jul; 17(7):609-18. PubMed ID: 3931104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sensitivity of arachidonic acid-induced platelet aggregation in the presence of carbon dioxide.
    Kerry PJ; Paton CJ
    Br J Pharmacol; 1984 Jan; 81(1):125-30. PubMed ID: 6423017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of platelet aggregation and arachidonate metabolism in streptozotocin-diabetic rats.
    Takahashi R; Morita I; Murota S; Ito H
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):123-9. PubMed ID: 2950527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired platelet response to thromboxane-A2 and defective calcium mobilization in a patient with a bleeding disorder.
    Lages B; Malmsten C; Weiss HJ; Samuelsson B
    Blood; 1981 Mar; 57(3):545-52. PubMed ID: 7459434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two phasic generation of thromboxane A2 by the action of collagen on rat platelets.
    Hanasaki K; Nakano T; Arita H
    Thromb Res; 1987 May; 46(3):425-36. PubMed ID: 2955543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subnormal platelet response to thromboxane A2 in a patient with chronic myeloid leukaemia.
    Okuma M; Takayama H; Uchino H
    Br J Haematol; 1982 Jul; 51(3):469-77. PubMed ID: 6809032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of etamsylate on platelet functions and arachidonic acid metabolism.
    Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H
    Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal platelet response to thromboxane A2.
    Wu KK; Le Breton GC; Tai HH; Chen YC
    J Clin Invest; 1981 Jun; 67(6):1801-4. PubMed ID: 6263954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
    Szczeklik A; Gryglewski RJ; Musiał J; Grodzínska L; Serwónska M; Wójcik-Switek L; Marcinkiewicz E
    Acta Biol Med Ger; 1978; 37(5-6):741-2. PubMed ID: 742286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the two pathways for arachidonate oxygenation in blood platelets.
    Dutilh CE; Haddeman E; Jouvenaz GH; Ten Hoor F; Nugteren DH
    Lipids; 1979 Feb; 14(2):241-6. PubMed ID: 34075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
    Raz A
    Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined effects of 2,3-DPG and Na-arachidonate on platelet aggregation and on TXA2 formation.
    Iatridis PG; Hadd H; Kotrotsou M; Iatridis SG
    Thromb Res; 1986 Apr; 42(2):177-85. PubMed ID: 3087007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension.
    Valeri CR; Macgregor H; Ragno G
    Transfusion; 2005 Apr; 45(4):596-603. PubMed ID: 15819682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.